You should not stay on peptide therapy indefinitely without monitoring, follow-up, and a clear reason for continuing
doi:10.1111/j.1365-2044.2007.04999.x Berger T, Green J, Horeczko T, et al
It was not clear how a drug that primarily affects glucose metabolism might directly impact the occurrence of cardiovascular events
Similarly, trials of semaglutide have shown substantial reductions in waist circumferencea clinical surrogate for visceral adiposityalongside improvements in cardiometabolic markers including hemoglobin A1c, blood pressure, and lipid profiles
Freschi M, Calori G, Piemonti L et al (2008) Glucagon improves insulin secretion from pig islets in vitro
Oxycodone has been shown to be 45% bound to human plasma proteins in vitro